Related Experiment Videos
[Abnormal movements and shaking in geriatrics (author's transl)].
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|March 8, 1979
Summary
Tiapride effectively treats neuroleptic-induced dyskinesia and alcohol-aggravated tremors. While its anxiolytic and anti-tremor effects are limited, especially in degenerative conditions, it shows excellent tolerance.
Area of Science:
- Neuropharmacology
- Movement Disorders
Background:
- Investigating the efficacy of tiapride, a selective dopamine D2/D3 receptor antagonist.
- Assessing tiapride's therapeutic potential in various movement disorders and conditions with tremor.
Observation:
- Tiapride was administered to 37 patients with abnormal movements and 20 with tremors of anxious-depressive origin.
- Clinical observations focused on the drug's impact on specific movement abnormalities and tremor severity.
Findings:
- Tiapride demonstrated optimal efficacy in treating lingual, buccal, and facial dyskinesia induced by neuroleptic medications.
- The drug was also effective for senile trembling exacerbated by alcohol consumption.
- Its anxiolytic and general anti-tremor properties were found to be more limited, with reduced effectiveness in degenerative senile tremors.
Implications:
- Tiapride is a valuable therapeutic option for specific neuroleptic-induced movement disorders and alcohol-related tremors.
- Further research may explore optimizing tiapride's use or combination therapies for broader tremor and anxiety indications.
- The excellent tolerance profile suggests a favorable safety margin for clinical application.